Maryland Technology News
These news items are provided from various selected
news sites and filtered through our keywords.
Technology News
FBI Fears Counterfeit Networking Equipment Could Compromise Security - InformationWeek Online Social Networking : The Employer's Dilemma A white paper which considers how relevant UK legislation and employers' policies impact on the use of social networking websites Google Steps Into Data Portability Dance with Friend Connect Google plans to release on Monday a preview version of Friend Connect, a service designed to let Web publishers add social networking features to their sites, the company said. ITU AFRICA - Ex-Orange CEO Pushes Developing World Broadband Sanjiv Ahuja left his role as CEO of Orange, the mobile phone and Internet access subsidiary of France Télécom, last year in order to seek a new challenge. With his new company Augere, he is now focused on rolling out broadband Internet access in parts of the world where penetration today is almost nonexistent -- and sees a need for desktop, not laptop, computers in developing countries. Vint Cerf Supports Municipal Broadband Networks Municipal broadband networks could help boost the availability of high-speed Internet access and even help to ensure Net neutrality in the U.S., said Vint Cerf, vice president and chief Internet evangelist at Google. Cablevision Plans Wi-Fi Network in NYC A day after Comcast and Time Warner Cable announced investments in a WiMax joint venture spearheaded by Sprint and Clearwire, Cablevision said it would build its own wireless broadband network, using Wi-Fi. Telkom Kenya Sends a Strong GSM Message Telkom Kenya has sent a strong message of its intention to compete in the tough GSM (Global System for Mobile Communications) market, signing a 9 billion Kenyan shilling (US$145.6 million) deal with Swedish telecommunications giant Ericsson.
Biotechnology News
SPOTLIGHT: Fledgling biotech hunts for cash The backers of a fledgling northern Virginia biotech named Cary Pharmaceuticals has been out beating the bushes for $14 million in new investment funds to carry the company into the clinic. So far, Read more... Osiris sells stem cell business to NuVasive Medical device maker NuVasive is buying Osteocel, Osiris' biologics business, for $35 million up front and an additional $50 million in milestone payments. The Osteocel business includes an adult Read more... Biotech M&A has yet to reach its peak In analyzing the PowerShares Dynamic Biotech & Genome ETF, a fund made up of primarily small- and medium-cap biotech stocks, Seeking Alpha notes that Big Pharma's appetite for biotech Read more... Flu Vaccine Makers To Set New Doses Record For Next Season, CSL Biotherapies, Sanofi Pasteur, Novartis Vaccines and Diagnostics, GlaxoSmithKline, and NEW YORK, May 10 (UPI) -- U.S. researchers said survey results show last year's flu vaccine fell far short, compared to past years, in keeping people from getting the virus. GeoVax Labs Inc. Secures $10 Million Financing Commitment ATLANTA, May 12 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. , an Atlanta- based HIV/AIDS vaccine development company, announced today that it has entered into a $10 million common stock purchase agreement with Fusion Capital Fund II, LLC, a Chicago-based institutional investor.
The Company may sell up to $10 million of its common stock to Fusion Capital from time to time over a 2...
Decoding Muscle Stem Cell Development, National Institutes of Health (NIH) Study MONDAY, May 12 (HealthDay News) -- Muscle stem cells can't grow into mature muscle cells if there aren't enough nutrients, according to a study that offers new insight into how developing muscle cells sense and respond to nutrient levels. Medical Research Should Include More Women Participants And Examine The Role Of Gender In Disease, Mayo Clinic Study EurekAlert -- Are the health needs of women adequately addressed by medical research as it is currently conducted? In the May issue of Mayo Clinic Proceedings, a team of Australian researchers and two cardiologists closely examine this question. Forest Laboratories, Inc. and Daiichi Sankyo Co Ltd. Announce the Termination of the AZOR Co-Promotion Agreement NEW YORK and PARSIPPANY, N.J., May 12 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. , a U.S.-based pharmaceutical company, and Daiichi Sankyo, Inc. today announced that they have terminated their co-promotion agreement for AZOR(TM)* (amlodipine and olmesartan medoxomil), Daiichi Sankyo's fixed-dose combination of two antihypertensives, the calcium channel blocker amlodipine besylate and...
East Bay Oakland: 10,000 New Jobs In Five Years; Life Sciences Sector Included; Expanding Biotech Program At Bizjournals -- Mayor Ron Dellums at his second economic summit on May 2 will present the economic development strategy for Oakland that was forged over the last year by the Oakland Partnership. Dellums' goals are to bring 10,000 new jobs to Oakland in the next five years, increase investment in the city and give Oakland residents better access to needed jobs. The priorities, the strategies and the... Novalar Pharmaceuticals, Inc. Receives FDA Approval for OraVerse(TM) SAN DIEGO, May 12 /PRNewswire/ -- Novalar Pharmaceuticals, Inc., a dental specialty pharmaceutical company, announced today that the United States Food and Drug Administration (FDA) has granted marketing approval for OraVerse(TM) (phentolamine mesylate). OraVerse is the first pharmaceutical agent indicated for the reversal of soft-tissue anesthesia and the associated functional deficits resulting from... Human Aging Gene Found In Flies, University of Oxford and Study ScienceDaily (May 12, 2008) Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have found a fast and effective way to investigate important aspects of human aging. Working at the University of Oxford and The Open University, Dr Lynne Cox and Dr Robert Saunders have discovered a gene in fruit flies that means flies can now be used to study the effects aging has... Nonprofits Ante Up Perks to Woo Star Scientists to Biotech Cluster Palm Beach -- Science is for rock stars. Only these superstars don't demand chilled Cristal champagne, washed and uncut fresh fruit and bendy straws, like singer Mariah Carey does for her dressing room. But they do enjoy some extra incentives, such as home mortgages and other perks, to move from prestigious research gigs elsewhere to the upstart science cluster in Florida. SomaLogic and Otsuka Pharmaceutical Co., Ltd. Enter Into Research Collaboration BOULDER, Colo., May 9 /PRNewswire/ -- SomaLogic, Inc. announced today that SomaLogic and Otsuka Pharmaceutical Co., Ltd. entered into a collaboration agreement to use SomaLogic's proprietary aptamer technology to discover and develop novel diagnostic products and to design research tools that will enhance Otsuka's pharmaceutical discovery and development efforts. Under the terms of the agreement, SomaLogic... Enzo Biochem Acquires Further Expanding Its Life Sciences Operations Acquisition Seen as Strategic and Accretive, Adding Management, Manufacturing and Scientific DepthNEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) announced the acquisition on May 8th of substantially all of the U.S. based assets of BIOMOL International, LP, of Plymouth Meeting, PA, and all of the stock of its two-wholly-owned United Kingdom subsidiaries. BIOMOL is a privately owned...
Otsuka Pharmaceutical Co., Ltd., Bristol-Myers Squibb Company ABILIFY(R) Receives Expanded Indications for Maintenance Treatment in Both Pediatric Patients (Aged 10-17) With Manic and Mixed Episodes of Bipolar I Disorder and Adolescents (Aged 13-17) With Schizophrenia TOKYO & PRINCETON, N.J.--(BUSINESS WIRE)--Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company (NYSE: BMY - News) announced that ABILIFY (aripiprazole) received expanded indications in Bipolar I Disorder and Schizophrenia. ABILIFY is now indicated for maintenance treatment of manic and mixed episodes associated with Bipolar I Disorder with or without psychotic features in pediatric patients... Celator Pharmaceuticals, Inc. Announces Appointment of as CEO PRINCETON, N.J., May 9 /PRNewswire/ -- Celator Pharmaceuticals today announced that Scott Jackson has been appointed Chief Executive Officer. Mr. Jackson joined Celator in October 2007 as Head of Commercial Development.
"We are delighted to have Scott as the new CEO. He brings more than 20 years of pharmaceutical experience, including 10 years of specialty pharmaceutical experience...
Osiris Therapeutics, Inc. Receives Approval for Use of Prochymal(TM) Under FDA Expanded Access Treatment Program COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ:OSIR - News) today announced it has been given clearance by the U.S. Food and Drug Administration (FDA) to initiate an expanded access treatment program for Prochymal, making the investigational stem cell product available to children with life-threatening Graft vs. Host Disease (GvHD). Prochymal, a formulation of adult mesenchymal stem... Par Pharmaceutical Companies, Inc. To Pay Spectrum Pharmaceuticals, Inc. $20M For Its Stake In Generic Injection WOODCLIFF LAKE, N.J., May 7 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it amended its agreement with Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) for $20 million in cash to increase its share of profits from the generic versions of GlaxoSmithKline's Imitrex(R) Injection, which will be immediately accretive to 2008 earnings and provide a strong return... Enzon Pharmaceuticals, Inc. Announces Plan to Spin-off Biotechnology Business BRIDGEWATER, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN - News) today announced that its Board of Directors has authorized a plan to spin-off its novel biotechnology business from Enzon in a transaction that will result in two independent and highly focused public companies.By separating these unique businesses into two focused companies, the opportunities for both...
Naturally-occuring Protein May Be Effective In Limiting Heart Attack Injury And Restoring Function, Medical College of Wisconsin Study ScienceDaily (May 7, 2008) Medical College of Wisconsin researchers in Milwaukee have shown for the first time that thrombopoietin (TPO), a naturally occurring protein being developed as a pharmaceutical to increase platelet count in cancer patients during chemotherapy, can also protect the heart against injury during a heart attack. Mistral Pharma Inc. Announces It will Not Combine with a Private U.S. Pharmaceutical Company MONTREAL, QUEBEC--(MARKET WIRE)--May 6, 2008 -- Mistral Pharma Inc. (CDNX:MIP.V - News) ("Mistral") today announced that it will not pursue the proposed combination with a private US-based specialty pharmaceutical company ("US Pharma Co.") announced on February 27, 2008 and has terminated the non-binding letter of intent to that effect. This decision is based on the Mistral's inability to meet different... ACT Biotech Acquires Clinical and Early Stage Oncology Portfolio Licenses From Bayer HealthCare SAN FRANCISCO and NEW YORK, May 7 /PRNewswire/ -- NGN Capital announced today the formation of ACT Biotech Inc., a new company dedicated to developing and commercializing targeted oral cancer drugs. ACT Biotech has entered into a license agreement with Bayer HealthCare LLC for a portfolio of clinical and early stage oncology assets. In conjunction with the agreement, ACT has raised $12 million...
Johnson and Johnson Pharmaceutical Research and Development, LLC (CA) Seven Clinical Presentations on Tapentadol Immediate Release for Acute Pain to Be Featured at 2008 American Pain Society Annual Meeting Phase 3 Safety and Efficacy Studies Will Be Highlighted
TAMPA, Fla., May 7 /PRNewswire-USNewswire/ -- Acute pain is a significant medical issue in the United States. More than 25 million Americans are said to experience acute pain each year as a result of injuries or surgeries, and a recent study estimated that 42 percent of U.S. hospital emergency department visits were due to pain...
